Postgraduate supervision
I welcome applications from both medically trained individuals and basic scientists to further research into the use of microfluidic devices as a platform for investigating human tissue responses to treatment. In addition I am particularly interested in tumour biology and the role of exosomes in disease and their use as biomarkers
Supervision record
PhD
Primary Supervisor
Samantha Drennan, 2013, (PhD) “Phenotypic and functional characterisation of regulatory T cells in head and neck squamous cell carcinoma”
Joanne Smith, 2016, (PhD) “The Effect of HNSCC-derived Soluble Factors on the Proliferation and Function of Immune Cells”
Second Supervisor
Hannah Beattie, Current (PhD) “Detection of novel biomarkers for identifying thyroid tumours using novel microfluidic technology”
James Dory, Current (PhD) “Investigating the effect of novel bispecifics targeting immunostimulatory molecules to target human tumour tissue using Hull's tissue-on-chip ex vivo platform”
Andrew Riley, 2020 (PhD) “An ex vivo thyroid-on-chip model for the elucidation of drug response and biomarker analysis”
Ruth Bower, 2018 (PhD) “A tumour-on-a-chip system for investigation of radiation based treatment in primary head and neck cancer: a personalised approach”
Elizabeth Roberts, 2018 (PhD) “Generation of an Immunosuppressive Microenvironment by Soluble Factors in Head and Neck Squamous Cell Carcinoma”
Ramsah Cheah, 2016 (PhD) “Monitoring the response of head and neck tumour tissue to irradiation using a microfluidic-based approach
MD
Primary Supervisor
Thomas Haigh, Current (MD) “Using microfluidic technology as a platform to identify exosomal biomarkers of thyroid disease”
Second Supervisor
Rishi Srivastava, 2017 (MD) “Radiation Response of Head and Neck Squamous Cell Carcinoma Using Early Markers of Apoptosis and Proliferation, Utilising a Microfluidic Approach”
Tosief Zahoor, 2016 (MD) “Does HPV-16 seropositivity correlate with T-cell distribution providing additional prognostic information in infected HNSCC patients?
Simon Carr, 2013 (MD) “Analysis of radiation-induced cell death in head and neck squamous cell carcinoma and rat liver maintained in microfluidic device”
Deborah Sylvester (2012 (MD) “Development of microfluidic based devices for studying tumour biology and evaluating treatment response in head and neck cancer biopsies”
MSc
Primary Supervisor
Jordan Lee Greaves, Current (MSc) “Exploiting microfluidic technology to predict chemoradiation responses in HNSCC”
Przemek Golebiewski, Current (MSc) “Development of bespoke microfluidic technology to identify thyroid tumour biomarkers”
Hayley Foster, 2022, (MSc) “Evaluating EV as a therapeutic target in Graves’ disease”
Second Supervisor
Jake Owen, Current (MSc) “Bioinformatic analysis of the effects of bispecifics on HNSCC tissue maintained on a microfluidic device”
Gordon McKensie, 2019 (MSc) “The effects of corticosteroids on immune modulating factors from Graves’ disease tissue maintained in a microfluidic device”
Beth Broughton, 2018 (MSc) “Characterisation of Intratumoral Immune Cells and Cytokines in Thyroid Cancer”
Chee Ching Chan, 2014 (MSc) “Analysis of Head and Neck Squamous Cell Carcinoma Tissue Maintained in a Micro fluidic Device Following Chemotherapy”